EADV 2026: Lebrikizumab improved hand and foot clearance, itch, and pain at 16 weeks versus placebo in a phase 3b atopic dermatitis trial.
News|Articles|September 14, 2005
Insect Bite with Lymphangitis
Author(s)David L. Kaplan, MD
A 70-year-old woman was bothered by a pruritic, reddened site on her left shoulder. The lesion progressed with a linear, erythematous eruption leading to her axilla and caused tender adenopathy.
Advertisement
A 70-year-old woman was bothered by a pruritic, reddened site on her left shoulder. The lesion progressed with a linear, erythematous eruption leading to her axilla and caused tender adenopathy.
The patient could not recall being bitten. However, a biopsy of tissue from the lesion confirmed the suspected diagnosis of a reaction to an insect bite with secondary lymphangitis.
A short course of prednisone completely resolved the signs and symptoms of the bite in this patient.
Advertisement
Related to this article
The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
Advertisement
Advertisement
Trending on Patient Care Online
1
Menopause Diagnoses Documented in Just 7.8% of Midlife Women's Outpatient Visits, Study Finds
2
JoAnn Pinkerton, MD, on Counseling Patients Starting Elinzanetant for VMS
3
Menopause Hormone Therapy Linked to Greater Weight Loss With Semaglutide in Real-World Study
4
Hormone Therapy Linked to More Frequent Migraines, but Not Greater Severity, in Postmenopausal Women
5